211 – 220 of 254
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness
(
- Contribution to journal › Article
-
Mark
Overdosing on immediate-release morphine solution has predictable adverse effects
(
- Contribution to journal › Letter
-
Mark
Breathlessness despite optimal pathophysiological treatment : on the relevance of being chronic
(
- Contribution to journal › Letter
-
Mark
In response to C Walshe, ‘The state of play’
(
- Contribution to journal › Letter
-
Mark
Risk factors for developing hypoxic respiratory failure in COPD
(
- Contribution to journal › Article
-
Mark
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness : Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol
(
- Contribution to journal › Article
-
Mark
A nationwide structure for valid Long-Term oxygen therapy : 29-Year prospective data in Sweden
(
- Contribution to journal › Article
-
Mark
Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups
(
- Contribution to journal › Article
-
Mark
Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
(
- Contribution to journal › Article
-
Mark
Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
(
- Contribution to journal › Letter